Psychiatry

Dr. Carbone will present during AAP 2021 about managing autism in pediatric practices.

Gastrointestinal symptoms were significantly linked to severe symptoms of depression and anxiety.

Relapse occurred in 39% of the maintenance group, compared to 56% in the discontinuation group.

Taste scores were significantly correlated with depression scores for both patients with irritable bowel syndrome and functional constipation.

Results show an increase in methamphetamine use, methamphetamine use disorder, and overdose mortality.

Dr. Diaz said patience is important in understanding the challenges patients with ADHD face during the COVID-19 pandemic.

Dr. Yamalis Diaz said ADHD is often under-diagnosed.

There was also a reduction of ASD diagnoses.

Anxiety, social support, mother-infant relationship, and infant temperament all improved after a 1-day CBT-based workshop.

There was an association between maternal BMI prepregnancy and offspring ADHD risk.

Many predict there will be a lasting labor shortage in nursing in the future.

The mortality rate has not declined since the 1970s.

Investigators push for a greater understanding of the disease in relation to the mental health of young patients, which has affected roughly 20% of the global pediatric population.

There are several clinical trials testing psychedelics as a treatment option for psychiatric disorders.

Sexual dysfunction in men was related to clinical factors, including erectile dysfunction, while women reported low emotional well-being and symptoms of anxiety.

Six-month paliperidone palmitate is the only twice-yearly injectable treatment for patients with schizophrenia.

A lack of PPE and high patient volumes were the leading causes of distress for nurses.

Depression is the leading cause of disability in the US.

There are a number of ongoing clinical trials testing psychedelics as a treatment for psychiatric disorders.

Patients with severe mental health issues often are linked to health inequalities that contribute to a shorter life expectancy than the general population.

Developed by BrainsWay, the new device has been shown to decrease anxiety symptoms in adult patients with anxious depression.

There was little difference in hospitalization and mortality rates between vaccinated schizophrenia patients and vaccinated control patients.

There has been a lot of variance in mental health studies during the COVID-19 pandemic.

Schizophrenia PRS was linked to increased disorganized symptom dimension scores.

More than half of DAA prescriptions were prescribed by specialists like gastroenterologist and infectious disease physicians.